about
Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach.Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives.Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study.Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis?Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis.Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre.Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis.Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect?Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experienceClinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 PatientsUnveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory DiseasesRituximab therapy for chronic periaortitisChanging patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritisUse of Interleukin-1 Blockers in Pericardial and Cardiovascular DiseasesA large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis
P50
Q36146582-F8224C1B-0814-49B0-A13F-00CA4986E9EFQ38279651-A903483D-28C0-4EC5-81A8-9B64E33BABDDQ38758286-95C21265-B71D-4927-8C31-571249D947FCQ38934972-F0876AB2-111F-4C5D-9EA0-67404416842CQ40212305-8F8F2A0C-6662-4AC7-AE60-66E0A21A7512Q40290985-D3BE6FCC-2651-4B96-BDD4-D1B34802735AQ40338767-8E32A694-19FE-4262-8DEA-938F94472443Q42706595-5D84EB26-3CBD-42F4-8DA0-B6B3350B4D0FQ43458709-7A9C7365-A73D-429C-B6CB-24F783589A22Q44764615-21F65533-0781-4DBC-8294-C160E471047EQ47705620-72E82AB4-F8C0-4657-98AE-FA088B97498CQ48229466-03DF0278-0E86-451E-81D5-453C1EABC79BQ49815749-B21024F6-55B0-4433-939F-83B58C19E68BQ58290821-A6E6FD90-2528-476A-884C-DADBA9D4B2EFQ64076130-DEEB528A-4C2D-4EA8-B4AB-976BB7E03D12Q64249669-8E696AAC-E39F-475A-A740-0D614CEAB48CQ84131913-15AF24C1-A50A-4541-8898-E6DA2434578FQ88580425-F32A5093-90B1-4814-A3AC-14A33379C5BDQ89110727-BE9D2762-5315-4A12-A4BA-B275E8D593F6Q90776691-CB3246BA-E64B-47BE-8F24-3F351C322471
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria Letizia Urban
@en
Maria Letizia Urban
@nl
type
label
Maria Letizia Urban
@en
Maria Letizia Urban
@nl
prefLabel
Maria Letizia Urban
@en
Maria Letizia Urban
@nl
P31
P496
0000-0003-1334-9538